Definium Therapeutics Inc. Common Shares vs Lattice Semiconductor Corporation Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.59B), while Lattice Semiconductor Corporation Common Stock trades at $127.91 (market cap $17.76B). The key difference: Lattice Semiconductor Corporation Common Stock is far larger — about 3.9× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is more actively traded (2,103,937 versus 1,802,283). Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Lattice Semiconductor Corporation Common Stock for 0 Days on average.
| DFTX | LSCC | |
|---|---|---|
Market Cap | $4.59B | $17.76B |
Volume | 2,103,937 | 1,802,283 |
Sector | Health | Technology |
52-Week High | $48.45 | $155.27 |
52-Week Low | $10.68 | $61.73 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $17.62B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Lattice Semiconductor develops low-power programmable chips, known as FPGAs. Its products are used in communications, computing, industrial, and automotive applications.
Read more on LSCC →